Acta Dermato Venereologica · 2023 · 15 citations · 26 references
MedicineDermatologyImmunologyImmunopathologyInflammationMolecular ImmunologyAntimicrobial PeptidesAtopic DermatitisImmunopathology Of SkinInflammatory DermatosesInflammatory Skin DiseasesInflammatory Skin DisordersAntibacterial PeptidesAntimicrobial Peptide Gene RegulationAntimicrobial Peptide RegulationAtopic Dermatitis ImmunopathologyAtopic Dermatitis PathologyBarrier Permeability RegulationInflammatory Skin ChangesInflammatory Skin Responses
Atopic dermatitis is an inflammatory skin disease characterized by significant permeability barrier damage. Regulation and maintenance of permeability and antimicrobial skin barriers are strongly connected. There is a lack of comprehensive studies of the expression of all 5 major antimicrobial peptide functional groups in atopic dermatitis. The aim of this study was to investigate the major antimicrobial peptide functional groups in lesional atopic dermatitis, non-lesional atopic dermatitis, and healthy control samples, using real-time quantitative PCR and immunohistochemistry. Lesional psoriatic skin was also examined as a diseased control. No differences in mRNA levels were detected between non-lesional atopic dermatitis and healthy control skin, and, at the protein level, the only change was the significantly decreased LL-37 in non-lesional atopic dermatitis. In lesional atopic dermatitis, several antimicrobial peptides were significantly altered at the mRNA level, while, at the protein level, all antimicrobial peptides were significantly upregulated or unchanged, except for LL-37, which decreased, compared with healthy controls. Antimicrobial peptides were similarly elevated in lesional atopic dermatitis and lesional psoriatic skin, with somewhat higher expression in lesional psoriatic skin, except for LL-37. In conclusion, LL-37 was the only antimicrobial peptide that was impaired in both non-lesional and lesional atopic dermatitis, highlighting its potential pathogenetic or exacerbating role in the initial stages of the disease.
26
Endogenous Antimicrobial Peptides and Skin Infections in Atopic Dermatitis
Peck Y. Ong, Takaaki Ohtake, Corinne Brandt et al. · New England Journal of Medicine · 2002 · 2K citations · Full text
Medicine, Dermatology, Immunology +17
Robert A. Dorschner, Vasumati K. Pestonjamasp, Seema Tamakuwala et al. · Journal of Investigative Dermatology · 2001 · 567 citations · Full text
Cytokine Milieu of Atopic Dermatitis Skin Subverts the Innate Immune Response to Vaccinia Virus
Michael Howell, Richard L. Gallo, Mark Boguniewicz et al. · Immunity · 2006 · 331 citations · Full text
Medicine, Dermatology, Immunology +17